Fri, March 24, 2023

Gregory Renza Reiterated (APTO) at Buy and Held Target at $75 on, Mar 24th, 2023

Gregory Renza of RBC Capital, Reiterated "Aptose Biosciences Inc." (APTO) at Buy and Held Target at $75 on, Mar 24th, 2023.

Gregory, nor any peers, have made any analyst calls on APTO in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30